Lv21
130 积分 2022-04-11 加入
Preclinical and Clinical Studies of Chidamide (CS055/HBI-8000), An Orally Available Subtype-selective HDAC Inhibitor for Cancer Therapy
3小时前
已完结
Species Differences in Pharmacokinetics and Pharmacodynamics
1个月前
已完结
PRMT5 supports multiple oncogenic pathways in mantle cell lymphoma
2个月前
已完结
Comparison of tucidinostat with CHOP-like versus CHOP-like in first-line treatment of peripheral T-cell lymphoma: a single-center real-world study
2个月前
已完结
Targeting S-adenosylmethionine biosynthesis with a novel allosteric inhibitor of Mat2A
4个月前
已完结
Discovery of AMG 193, an MTA-Cooperative PRMT5 Inhibitor for the Treatment of MTAP-Deleted Cancers
4个月前
已完结
Dosage-effect of selenium supplementation on blood glucose and oxidative stress in type 2 diabetes mellitus and normal mice
4个月前
已完结
Abstract 3319: The MTA-cooperative PRMT5 inhibitor, MRTX1719, demonstrates increased anti-tumor activity in combination with KRAS mutant-selective inhibitors in MTAP del,KRAS-mutant cancers
4个月前
已关闭
A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models
4个月前
已完结
Progress in developing MNK inhibitors
5个月前
已完结
皖公网安备34019202002308
